Search for Clinical Trial Results

Sponsored By

Acute Graft Versus Host Disease - 162 Studies Found

Status Study
Recruiting Study Name: Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease
Condition: Acute Graft-versus-host Disease
Date: 2013-01-05
Interventions:
  • Biological: Mesenchymal stem cells

Active, not recruiting Study Name: Study of INCB039110 in Combination With Corticosteroids for the Treatment of Acute GVHD
Condition: Acute Graft Versus Host Disease
Date: 2015-11-20
Interventions:
  • Drug: INCB039110 (200 mg)
  • Drug: INCB039110
Terminated Study Name: Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Condition: Acute Graft Versus Host Disease
Date: 2011-11-16
Interventions: Drug: Tocilizumab Tocilizumab will be administered intravenously at a dose of 8 mg/kg once every three w
Terminated Study Name: Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD
Condition: Acute Graft Versus Host Disease
Date: 2002-06-05
Interventions: Drug: Recombinant Human Keratinocyte Growth Factor
Withdrawn Study Name: Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
Condition: Acute Graft Versus Host Disease
Date: 2008-03-04
Interventions: Biological: IT-Combination The treatment consists of a standard dose of 4 infusions of IT-combination (4
Not yet recruiting Study Name: Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
Condition: Acute-graft-versus-host Disease
Date: 2015-03-09
Interventions:
  • Drug: Cannabidiol Oral cannabi
Completed Study Name: The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
Condition: Acute Graft Versus Host Disease
Date: 2008-07-28
Interventions: Drug: Etanercept (Enbrel) Etanercept will begin within 72 hours of the diagnosis of Grade I acute GVHD a
Not yet recruiting Study Name: GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Condition: Acute Graft-versus-host Disease
Date: 2017-05-02
Interventions:
  • Drug: Itacitinib Itacitinib at
Recruiting Study Name: Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease
Condition: Acute Graft Versus Host Disease
Date: 2014-05-06
Interventions:
  • Drug: natalizumab Natalizumab

Terminated Study Name: Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease
Condition: Acute Graft-versus-Host Disease
Date: 2006-01-24
Interventions:
  • Drug: Methoxsalen+ECP, Methylprednisolone

Next >>>